Skip to main navigation
  • Bicycle Pharmaceuticals

Site Top Navigation

  • Publications
  • Investors & Media
    • Investor Overview
    • Press Releases
    • Investor Events
    • SEC Filings
    • Stock Information
    • Analyst Coverage
    • Corporate Governance
    • Investor FAQs
    • Email Alerts
    • Contact IR
  • Contact Us
  • About
  • Approach
    • Therapies
    • Platform
    • Screening
    • Opportunity
  • Programs
  • Beyond Oncology
  • Patients
  • Careers
  • Publications
  • Investors & Media
    • Overview
    • Press Releases
    • Investor Events
    • SEC Filings
    • Stock Information
    • Analyst Coverage
    • Corporate Governance
    • Investor FAQs
    • Email Alerts
    • Contact IR
  • Contact Us
Committee Composition
  • Investor Overview
  • Press Releases
  • Events
  • SEC Filings
  • Annual General Meeting
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
  • Analyst Coverage
  • Corporate Governance
    • Documents
    • Leadership
    • Committee Composition
  • Resources
    • Investor FAQs
    • Email Alerts
    • Contact IR

Committee Composition

Committee Composition

Audit Compensation Nominating & Corporate Governance Strategic
Kate Bingham Audit Nominating & Corporate Governance
Janice Bourque Audit Compensation Nominating & Corporate Governance
Veronica Jordan, Ph.D. Compensation
Richard Kender Audit Compensation Strategic
Kevin Lee, Ph.D., MBA Strategic
Pierre Legault, MBA, CPA  Strategic
= Chairperson = Member = Chairman of the Board

Shareholder tools

Bicycle Therapeutics
  • Privacy Policy
  • Contact
Twitter LinkedIn Instagram
© Bicycle Therapeutics